Robotic surgery in inflammatory bowel disease: a systematic review.
- 1IBD Outpatient Clinics, Pontifícia Universidade Católica Do Paraná (PUCPR), Curitiba, Brazil.
- 2Hospital Santa Izabel, Salvador, Bahia, Brazil.
- 3Einstein Hospital Israelita, São Paulo, Brazil. [email protected].
Abstract
Background
Surgical treatment remains an essential component in the management of inflammatory bowel disease (IBD) despite advances in medical therapy. Although minimally invasive surgery is preferred, technical challenges related to chronic inflammation and altered anatomy may limit laparoscopic approaches. Robotic surgery has been increasingly adopted, but its role in IBD surgery remains to be clearly defined.Objectives
To synthesize the available evidence on the feasibility, safety, and perioperative outcomes of robotic surgery in patients with IBD.Methods
A systematic review was conducted according to PRISMA guidelines. Studies were identified through an electronic search of the PubMed database for reports evaluating outcomes of robotic surgery in IBD. Eligible studies included case series, comparative studies, and systematic reviews published in English. Primary outcomes were conversion to open surgery and postoperative complications; secondary outcomes included operative time, length of stay (LOS), reoperation, readmission, and anastomotic leak.Results
Thirty-four studies were included. Robotic surgery was consistently associated with longer operative time. However, postoperative morbidity, major complications, anastomotic leak, reoperation, and mortality rates were comparable between techniques. Robotic approaches demonstrated lower and favorable conversion rates, particularly in complex inflammatory phenotypes or pelvic procedures. Length of stay and estimated blood loss were similar or numerically lower in several robotic cohorts.Conclusion
Robotic surgery is a safe and feasible minimally invasive approach for IBD patients, with perioperative outcomes comparable to conventional surgery. Its potential advantages may be most relevant in complex or technically demanding cases, although high-quality prospective studies are needed to better define its role.
Related
- Diagnostic accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) for inflammatory bowel disease: a systematic review and bivariate diagnostic meta-analysis.
- Dietary Polyphenols as Adjunctive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for prevention
- The Therapeutic Potential of Berry-Derived and Berry-Based Interventions in Inflammatory Bowel Disease: A Comprehensive Systematic Review of Preclinical and Clinical Evidence
- Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease.
BibTeX
@article{todescatto2026robotic,
title = {{Robotic surgery in inflammatory bowel disease: a systematic review.}},
author = {Alexandra Damasio Todescatto and Carlos Ramon Silveira Mendes and Sergio Eduardo Alonso Araujo and Paulo Gustavo Kotze},
journal = {International journal of colorectal disease},
year = {2026},
month = aug,
doi = {10.1007/s00384-026-05213-8},
url = {https://europepmc.org/article/MED/42957792},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Robotic surgery in inflammatory bowel disease: a systematic review.
AU - Alexandra Damasio Todescatto
AU - Carlos Ramon Silveira Mendes
AU - Sergio Eduardo Alonso Araujo
AU - Paulo Gustavo Kotze
PY - 2026
DA - 2026/08/04
JO - International journal of colorectal disease
DO - 10.1007/s00384-026-05213-8
UR - https://europepmc.org/article/MED/42957792
AB - Background Surgical treatment remains an essential component in the management of inflammatory bowel disease (IBD) despite advances in medical therapy. Although minimally invasive surgery is preferred, technical challenges related to chronic inflammation and altered anatomy may limit laparoscopic approaches. Robotic surgery has been increasingly adopted, but its role in IBD surgery remains to be clearly defined.Objectives To synthesize the available evidence on the feasibility, safety, and perioperative outcomes of robotic surgery in patients with IBD.Methods A systematic review was conducted according to PRISMA guidelines. Studies were identified through an electronic search of the PubMed database for reports evaluating outcomes of robotic surgery in IBD. Eligible studies included case series, comparative studies, and systematic reviews published in English. Primary outcomes were conversion to open surgery and postoperative complications; secondary outcomes included operative time, length of stay (LOS), reoperation, readmission, and anastomotic leak.Results Thirty-four studies were included. Robotic surgery was consistently associated with longer operative time. However, postoperative morbidity, major complications, anastomotic leak, reoperation, and mortality rates were comparable between techniques. Robotic approaches demonstrated lower and favorable conversion rates, particularly in complex inflammatory phenotypes or pelvic procedures. Length of stay and estimated blood loss were similar or numerically lower in several robotic cohorts.Conclusion Robotic surgery is a safe and feasible minimally invasive approach for IBD patients, with perioperative outcomes comparable to conventional surgery. Its potential advantages may be most relevant in complex or technically demanding cases, although high-quality prospective studies are needed to better define its role.
SN - 0179-1958
SN - 1432-1262
ER -